Psychopharmacologic Drugs Advisory Committee; Cancellation

---
identifier: "/us/fr/E6-14293"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Psychopharmacologic Drugs Advisory Committee; Cancellation"
title_number: 0
title_name: "Federal Register"
section_number: "E6-14293"
section_name: "Psychopharmacologic Drugs Advisory Committee; Cancellation"
positive_law: false
currency: "2006-08-29"
last_updated: "2006-08-29"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E6-14293"
document_type: "notice"
publication_date: "2006-08-29"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "71 FR 51198"
fr_volume: 71
fr_action: "Notice."
---


#  Psychopharmacologic Drugs Advisory Committee; Cancellation

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The meeting of the Psychopharmacologic Drugs Advisory Committee scheduled for September 7, 2006, is cancelled. This amended meeting was announced in the *Federal Register* of August 17, 2006 (71 FR 47502).

**FOR FURTHER INFORMATION CONTACT:**

Cicely Reese, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512544. Please call the Information Line for up-to-date information on this meeting.

Dated: August 23, 2006.

Randall W. Lutter,

Associate Commissioner for Policy and Planning.